HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization.
The Brazilian Network for HIV Isolation and Characterization was established for the surveillance of HIV variability in Brazil. Here, we report characterization of HIV strains and virus-specific immune responses from 35 clinical samples collected from three potential HIV vaccine sites. Three genetic subtypes of HIV-1 were identified by heteroduplex mobility assay (HMA) B (in 82.9% of the samples), F (14.3%), and C (2.9%). Phylogenetic analysis based on the C2V3/env DNA sequence from all 25 specimens examined was 100% concordant with HMA results. Four variants of subtype B with different tetrapeptides at the tip of the V3 loop were found: the GPGR motif (North American), GWGR motif (Brazilian B"), and two minor variants, GFGR and GPGS, as previously detected. No significant association was found between HIV-1 subtypes and the mode of transmission or biologic properties of HIV-1 isolates (derived from 88.6% of the specimens). Only 5 of 16 isolates studied were neutralized by the autologous sera. Consistent with previous results, no relation between viral subtype and peptide enzyme-linked immunosorbent assay (ELISA) seroreactivity or neutralization was evident. This study also demonstrated the effectiveness of the collaborative approach followed by Brazilian scientists when addressing a complex subject such as HIV variability.
Bongertz
V
V
Departamento de Imunologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Bou-Habib
D C
DC
Brígido
L F
LF
Caseiro
M
M
Chequer
P J
PJ
Couto-Fernandez
J C
JC
Ferreira
P C
PC
Galvão-Castro
B
B
Greco
D
D
Guimarães
M L
ML
Linhares de Carvalho
M I
MI
Morgado
M G
MG
Oliveira
C A
CA
Osmanov
S
S
Ramos
C A
CA
Rossini
M
M
Sabino
E
E
Tanuri
A
A
Ueda
M
M
D016915:AIDS Vaccines; D000293:Adolescent; D000328:Adult; D000595:Amino Acid Sequence; D001938:Brazil / Q000453:epidemiology; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000032:analysis; D015658:HIV Infections / Q000453:epidemiology* / Q000821:virology; D015497:HIV-1 / Q000145:classification* / Q000235:genetics / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000032:analysis; D010802:Phylogeny; D012307:Risk Factors; D017421:Sequence Analysis
D016915:AIDS Vaccines; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments